<DOC>
	<DOC>NCT01983553</DOC>
	<brief_summary>The purpose of this study is to conduct a passive surveillance of hospitalized dengue cases in subjects who participated in study CYD23 (NCT00842530). The Objectives are: - To describe the incidence of virologically-confirmed hospitalized dengue cases. - To characterize hospitalized dengue cases. - To evaluate the occurrence of related and fatal serious adverse events (SAEs).</brief_summary>
	<brief_title>Long-Term Study of Hospitalized Dengue &amp; Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study</brief_title>
	<detailed_description>This study will be a passive surveillance of hospitalized dengue cases in subjects who participated in study CYD23 (NCT00842530) where subjects were initially randomized to receive 3 injections of either CYD dengue vaccine or control at 6 month intervals. Any SAE related to a study procedure or related to a previous injection from study CYD23, or any fatal SAEs (even if unrelated) will be reported to the Sponsor. An Independent Data Monitoring Committee (IDMC) will also be involved in the regular review of virologically-confirmed hospitalized dengue cases. Any fatal outcome or related SAE will be promptly reviewed by the IDMC. No study vaccinations will be administered in this protocol.</detailed_description>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Dengue</mesh_term>
	<mesh_term>Hemorrhagic Fevers, Viral</mesh_term>
	<mesh_term>Severe Dengue</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Ongoing participation in study CYD23 at the time of enrollment Assent form has been signed and dated by the subject (for subjects â‰¥ 7 years old), and informed consent form has been signed and dated by the parent(s) or another legally acceptable representative and by 2 independent witnesses. Subject and parent/legally acceptable representative are able to attend all scheduled visits and to comply with all study procedures. Planned participation in another dengue clinical trial during the present study Deprived of freedom by an administrative or court order, or in an emergency setting, or hospitalized involuntarily.</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Dengue Virus</keyword>
	<keyword>Dengue Fever</keyword>
	<keyword>Dengue Hemorrhagic Fever</keyword>
	<keyword>CYD Dengue Vaccine</keyword>
</DOC>